Patents by Inventor Anna Sergeeva

Anna Sergeeva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
    Patent number: 11192958
    Abstract: The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-1 in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune-related diseases are also provided.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jeffrey Molldrem, Anna Sergeeva
  • MONOCLONAL ANTIBODIES FOR USE IN DIAGNOSIS AND THERAPY OF CANCERS AND AUTOIMMUNE DISEASE
    Publication number: 20180371106
    Abstract: The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-1 in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune-related diseases are also provided.
    Type: Application
    Filed: February 13, 2018
    Publication date: December 27, 2018
    Applicant: Board of Regents, The University of Texas System
    Inventors: Jeffrey MOLLDREM, Anna SERGEEVA
  • Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
    Patent number: 9926380
    Abstract: The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-1 in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune-related diseases are also provided.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: March 27, 2018
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jeffrey Molldrem, Anna Sergeeva
  • MONOCLONAL ANTIBODIES FOR USE IN DIAGNOSIS AND THERAPY OF CANCERS AND AUTOIMMUNE DISEASE
    Publication number: 20150191546
    Abstract: The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-1 in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune-related diseases are also provided.
    Type: Application
    Filed: July 3, 2013
    Publication date: July 9, 2015
    Applicant: Board of Regents, The University of Texas System
    Inventors: Jeffrey Molldrem, Anna Sergeeva
  • Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease
    Publication number: 20110293620
    Abstract: The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-I in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune-related diseases are also provided.
    Type: Application
    Filed: December 7, 2009
    Publication date: December 1, 2011
    Inventors: Jeffrey J. Molldrem, Anna Sergeeva